Trials / Completed
CompletedNCT02226588
Comparison of Primary and Secondary Prevention of Postpartum Hemorrhage at the Community Level in Egypt
Two Community Strategies Comparing Use of Misoprostol for Secondary Prevention to Primary Prevention for Postpartum Hemorrhage: A Randomized Cluster Non-Inferiority Study in El Beheira Governorate, Egypt
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 2,827 (actual)
- Sponsor
- Gynuity Health Projects · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Accepted
Summary
The objective of this study is to compare two community-level strategies: either selective, early administration of 800 mcg sublingual misoprostol to women for secondary prevention of postpartum hemorrhage (PPH) or universal use of 600 mcg oral misoprostol at the time of delivery for prophylaxis of PPH. The significance of this cluster randomized non-inferiority trial is its potential to inform service delivery programs on clinical outcomes, program feasibility, cost, and acceptability of two different community models of PPH care using misoprostol.1. The study hypothesizes that a service delivery model that administers misoprostol for secondary prevention is non-inferior to a model that administers misoprostol for universal prophylaxis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Misoprostol |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2016-01-01
- Completion
- 2016-01-01
- First posted
- 2014-08-27
- Last updated
- 2016-02-15
Locations
2 sites across 1 country: Egypt
Source: ClinicalTrials.gov record NCT02226588. Inclusion in this directory is not an endorsement.